OpGen, Inc. (OPGN)
 OTCMKTS  · Delayed Price · Currency is USD  
0.0002
 0.00 (0.00%)
  Oct 29, 2025, 4:00 PM EDT
OpGen Market Cap
OpGen has a market cap or net worth of $2.01 thousand as of October 30, 2025. Its market cap has decreased by -99.95% in one year.
Market Cap 
 2.01K
Enterprise Value 
 870.66K
Revenue 
 5.03M
Ranking 
 n/a
PE Ratio 
 0.00
Stock Price 
$0.00
Market Cap Chart
Since May 5, 2015, OpGen's market cap has decreased from 51.90M to 2.01K, a decrease of -100.00%. That is a compound annual growth rate of -62.02%.
Market Cap History
| Date | Market Cap | % Change | 
|---|---|---|
| Oct 28, 2025 | 2.01K | -99.97% | 
| Dec 31, 2024 | 5.99M | 42.44% | 
| Dec 29, 2023 | 4.21M | -44.45% | 
| Dec 30, 2022 | 7.57M | -80.56% | 
| Dec 31, 2021 | 38.95M | -15.10% | 
| Dec 31, 2020 | 45.88M | 1,069.17% | 
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | 
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | 
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro | 
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro | 
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | 
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
 Full DefinitionRelated Stocks
| Company | Market Cap | 
|---|---|
| Veradigm | 815.18M | 
| Elite Pharmaceuticals | 648.67M | 
| Glass House Brands | 563.30M | 
| Northwest Biotherapeutics | 355.88M | 
| Silence Therapeutics | 341.50M | 
| Nika Pharmaceuticals | 312.10M | 
| CytoDyn | 303.60M | 
| American Oncology Network | 297.14M |